Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
LDK378 showed a marked clinical response in 78 patients with anaplastic lymphoma kinase positive (ALK+) metastatic non-small cell lung cancer (NSCLC) who had progressed during or after crizotinib therapy or had not been previously treated with crizotinib
Jpn J Antibiot
Chemical Name: 4-((2R
Efinaconazole exhibits in vitro minimum inhibitory concentrations (MICs) of 0
Capravirine
Idebenone Catalog No.:M9526-2 LDK378 showed a marked clinicalIdebenone, also known as CV 2619, ss a drug that was initially developed by Takeda Pharmaceutical Company for the treatment of Alzheimer's disease and other cognitive defects. As of December 2013 the drug is not approved for these indications in North America or Europe, but it is approved for the treatment of Leber's hereditary optic neuropathy (LHON) in Europe. Product information CAS Number: 58186 27 9 Molecular Weight: 338. 44 Formula: C19H30O5
US$ 14.65
US$ 18.19
US$ 68.00
US$ 19.99